
Atara Biotherapeutics ATRA
$ 5.17
-4.08%
Quarterly report 2025-Q3
added 11-12-2025
Atara Biotherapeutics Cash Conversion Cycle 2011-2026 | ATRA
Annual Cash Conversion Cycle Atara Biotherapeutics
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 50.4 | 1.58 K | 118 | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 1.58 K | 50.4 | 584 |
Quarterly Cash Conversion Cycle Atara Biotherapeutics
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | 4.81 | - | 4.27 | 60.9 | 117 | - | 14.3 | 43.1 | 1.51 K | - | 9.07 | 1.15 | 10.3 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 1.51 K | 1.15 | 178 |
Cash Conversion Cycle of other stocks in the Biotechnology industry
| Issuer | Cash Conversion Cycle | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Acorda Therapeutics
ACOR
|
117 | - | -24.86 % | $ 820 K | ||
|
AgeX Therapeutics
AGE
|
-8.96 K | - | -10.17 % | $ 12.2 K | ||
|
AbCellera Biologics
ABCL
|
173 | $ 3.54 | -2.48 % | $ 1.06 B | ||
|
I-Mab
IMAB
|
-1.97 K | - | - | $ 866 M | ||
|
ADMA Biologics
ADMA
|
355 | $ 15.85 | -4.2 % | $ 3.78 B | ||
|
Alexion Pharmaceuticals, Inc.
ALXN
|
12.8 | - | - | $ 40.3 B | ||
|
Aptorum Group Limited
APM
|
-400 | $ 0.82 | -0.79 % | $ 4.47 M | ||
|
EyeGate Pharmaceuticals, Inc.
EYEG
|
17 | - | -1.52 % | $ 24.7 M | ||
|
Midatech Pharma plc
MTP
|
82.8 | - | -18.52 % | $ 27.3 M | ||
|
Alpine Immune Sciences
ALPN
|
154 | - | - | $ 2.17 B | ||
|
Apellis Pharmaceuticals
APLS
|
115 | $ 20.39 | 2.67 % | $ 2.57 B | ||
|
Ampio Pharmaceuticals
AMPE
|
-2.85 K | - | -11.43 % | $ 502 K | ||
|
ANI Pharmaceuticals
ANIP
|
235 | $ 75.33 | -1.57 % | $ 1.46 B | ||
|
Институт стволовых клеток человека
ISKJ
|
104 | - | - | - | ||
|
AVEO Pharmaceuticals
AVEO
|
-123 | - | - | $ 521 M | ||
|
Corcept Therapeutics Incorporated
CORT
|
-402 | $ 34.4 | -3.61 % | $ 3.57 B | ||
|
Axsome Therapeutics
AXSM
|
-256 | $ 162.29 | -1.09 % | $ 8.07 B | ||
|
CorMedix
CRMD
|
-215 K | $ 6.52 | -8.43 % | $ 332 M | ||
|
Champions Oncology
CSBR
|
1.94 | $ 5.85 | -2.58 % | $ 79.9 M | ||
|
BridgeBio Pharma
BBIO
|
-114 | $ 64.94 | -2.41 % | $ 12.4 B | ||
|
BioDelivery Sciences International
BDSI
|
340 | - | -4.8 % | $ 255 M | ||
|
Acasti Pharma
ACST
|
1.97 | - | 4.01 % | $ 150 M | ||
|
BeiGene, Ltd.
BGNE
|
52.6 | - | 0.49 % | $ 251 B | ||
|
Denali Therapeutics
DNLI
|
1.89 | $ 19.72 | -3.19 % | $ 3.24 B | ||
|
Bellicum Pharmaceuticals
BLCM
|
6.09 | - | -9.72 % | $ 5.89 M | ||
|
Berkeley Lights
BLI
|
214 | - | -7.31 % | $ 87 M | ||
|
Edesa Biotech
EDSA
|
97.1 | $ 3.91 | -8.43 % | $ 12.5 M | ||
|
Aeterna Zentaris
AEZS
|
-34.3 K | - | 5.93 % | $ 314 M | ||
|
BioMarin Pharmaceutical
BMRN
|
733 | $ 60.59 | 0.26 % | $ 11.6 B | ||
|
Equillium
EQ
|
33.2 | $ 1.7 | -3.14 % | $ 59 M |